Market Research Logo

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Intravenous Immunoglobulin (IVIg) Market 2018, Forecast to 2023

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Intravenous Immunoglobulin (IVIg) Market 2018, Forecast to 2023

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Scope of the Report:
This report focuses on the Intravenous Immunoglobulin (IVIg) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America region is the largest supplier of intravenous immunoglobulin (IVIg), with a production market share nearly 48% in 2016. Europe is the second largest supplier of intravenous immunoglobulin (IVIg), enjoying production market share nearly 23% in 2016.
North America is the largest sales place, with a sales market share nearly 44% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 22%.
Market competition is intense. Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Intravenous Immunoglobulin (IVIg) is expected to grow at a CAGR of roughly 6.0% over the next five years, will reach 11500 million US$ in 2023, from 8120 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
IVIg Liquid
IVIg Powder

Market Segment by Applications, can be divided into
Immunodeficiency
Autoimmune Disease
Acute Infection

There are 15 Chapters to deeply display the global Intravenous Immunoglobulin (IVIg) market.
Chapter 1, to describe Intravenous Immunoglobulin (IVIg) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Intravenous Immunoglobulin (IVIg), with sales, revenue, and price of Intravenous Immunoglobulin (IVIg), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Intravenous Immunoglobulin (IVIg), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Intravenous Immunoglobulin (IVIg) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Intravenous Immunoglobulin (IVIg) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


1 Market Overview
1.1 Intravenous Immunoglobulin (IVIg) Introduction
1.2 Market Analysis by Type
1.2.1 IVIg Liquid
1.2.2 IVIg Powder
1.3 Market Analysis by Applications
1.3.1 Immunodeficiency
1.3.2 Autoimmune Disease
1.3.3 Acute Infection
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Business Overview
2.1.1.1 Baxter Description
2.1.1.2 Baxter Headquarter, Main Business and Finance Overview
2.1.2 Baxter Intravenous Immunoglobulin (IVIg) Product Introduction
2.1.2.1 Intravenous Immunoglobulin (IVIg) Production Bases, Sales Regions and Major Competitors
2.1.2.2 Intravenous Immunoglobulin (IVIg) Product Information
2.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Baxter Intravenous Immunoglobulin (IVIg) Market Share in 2017
2.2 Grifols
2.2.1 Business Overview
2.2.1.1 Grifols Description
2.2.1.2 Grifols Headquarter, Main Business and Finance Overview
2.2.2 Grifols Intravenous Immunoglobulin (IVIg) Product Introduction
2.2.2.1 Intravenous Immunoglobulin (IVIg) Production Bases, Sales Regions and Major Competitors
2.2.2.2 Intravenous Immunoglobulin (IVIg) Product Information
2.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Grifols Intravenous Immunoglobulin (IVIg) Market Share in 2017
2.3 CSL
2.3.1 Business Overview
2.3.1.1 CSL Description
2.3.1.2 CSL Headquarter, Main Business and Finance Overview
2.3.2 CSL Intravenous Immunoglobulin (IVIg) Product Introduction
2.3.2.1 Intravenous Immunoglobulin (IVIg) Production Bases, Sales Regions and Major Competitors
2.3.2.2 Intravenous Immunoglobulin (IVIg) Product Information
2.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global CSL Intravenous Immunoglobulin (IVIg) Market Share in 2017
2.4 Octapharma
2.4.1 Business Overview
2.4.1.1 Octapharma Description
2.4.1.2 Octapharma Headquarter, Main Business and Finance Overview
2.4.2 Octapharma Intravenous Immunoglobulin (IVIg) Product Introduction
2.4.2.1 Intravenous Immunoglobulin (IVIg) Production Bases, Sales Regions and Major Competitors
2.4.2.2 Intravenous Immunoglobulin (IVIg) Product Information
2.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Octapharma Intravenous Immunoglobulin (IVIg) Market Share in 2017
2.5 Biotest
2.5.1 Business Overview
2.5.1.1 Biotest Description
2.5.1.2 Biotest Headquarter, Main Business and Finance Overview
2.5.2 Biotest Intravenous Immunoglobulin (IVIg) Product Introduction
2.5.2.1 Intravenous Immunoglobulin (IVIg) Production Bases, Sales Regions and Major Competitors
2.5.2.2 Intravenous Immunoglobulin (IVIg) Product Information
2.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Biotest Intravenous Immunoglobulin (IVIg) Market Share in 2017
2.6 Kedrion
2.6.1 Business Overview
2.6.1.1 Kedrion Description
2.6.1.2 Kedrion Headquarter, Main Business and Finance Overview
2.6.2 Kedrion Intravenous Immunoglobulin (IVIg) Product Introduction
2.6.2.1 Intravenous Immunoglobulin (IVIg) Production Bases, Sales Regions and Major Competitors
2.6.2.2 Intravenous Immunoglobulin (IVIg) Product Information
2.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Kedrion Intravenous Immunoglobulin (IVIg) Market Share in 2017
2.7 Hualan Bio
2.7.1 Business Overview
2.7.1.1 Hualan Bio Description
2.7.1.2 Hualan Bio Headquarter, Main Business and Finance Overview
2.7.2 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Introduction
2.7.2.1 Intravenous Immunoglobulin (IVIg) Production Bases, Sales Regions and Major Competitors
2.7.2.2 Intravenous Immunoglobulin (IVIg) Product Information
2.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Hualan Bio Intravenous Immunoglobulin (IVIg) Market Share in 2017
2.8 CNBG
2.8.1 Business Overview
2.8.1.1 CNBG Description
2.8.1.2 CNBG Headquarter, Main Business and Finance Overview
2.8.2 CNBG Intravenous Immunoglobulin (IVIg) Product Introduction
2.8.2.1 Intravenous Immunoglobulin (IVIg) Production Bases, Sales Regions and Major Competitors
2.8.2.2 Intravenous Immunoglobulin (IVIg) Product Information
2.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global CNBG Intravenous Immunoglobulin (IVIg) Market Share in 2017
2.9 Shanghai RAAS
2.9.1 Business Overview
2.9.1.1 Shanghai RAAS Description
2.9.1.2 Shanghai RAAS Headquarter, Main Business and Finance Overview
2.9.2 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Introduction
2.9.2.1 Intravenous Immunoglobulin (IVIg) Production Bases, Sales Regions and Major Competitors
2.9.2.2 Intravenous Immunoglobulin (IVIg) Product Information
2.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Shanghai RAAS Intravenous Immunoglobulin (IVIg) Market Share in 2017
2.10 CBPO
2.10.1 Business Overview
2.10.1.1 CBPO Description
2.10.1.2 CBPO Headquarter, Main Business and Finance Overview
2.10.2 CBPO Intravenous Immunoglobulin (IVIg) Product Introduction
2.10.2.1 Intravenous Immunoglobulin (IVIg) Production Bases, Sales Regions and Major Competitors
2.10.2.2 Intravenous Immunoglobulin (IVIg) Product Information
2.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global CBPO Intravenous Immunoglobulin (IVIg) Market Share in 2017
2.11 LFB Group
2.11.1 Business Overview
2.11.2 LFB Group Intravenous Immunoglobulin (IVIg) Product Introduction
2.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 BPL
2.12.1 Business Overview
2.12.2 BPL Intravenous Immunoglobulin (IVIg) Product Introduction
2.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sichuan Yuanda Shuyang
2.13.1 Business Overview
2.13.2 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Introduction
2.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Intravenous Immunoglobulin (IVIg) Market Competition, by Manufacturer
3.1 Global Intravenous Immunoglobulin (IVIg) Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Intravenous Immunoglobulin (IVIg) Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share in 2017
3.4.2 Top 5 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Intravenous Immunoglobulin (IVIg) Market Analysis by Regions
4.1 Global Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Regions
4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Regions (2013-2018)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Regions (2013-2018)
4.2 North America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2013-2018)
5 North America Intravenous Immunoglobulin (IVIg) by Countries, Type, Application and Manufacturers
5.1 North America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Countries
5.1.1 North America Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
5.1.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
5.1.3 United States Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
5.1.4 Canada Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
5.1.5 Mexico Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
5.2 North America Intravenous Immunoglobulin (IVIg) Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2017)
5.2.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2017)
5.3 North America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Type (2013-2018)
5.3.2 North America Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Type (2013-2018)
5.4 North America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Application (2013-2018)
5.4.2 North America Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Application (2013-2018)
6 Europe Intravenous Immunoglobulin (IVIg) by Countries, Type, Application and Manufacturers
6.1 Europe Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Countries
6.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
6.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
6.1.3 Germany Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
6.1.4 UK Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
6.1.5 France Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
6.1.6 Russia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
6.1.7 Italy Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
6.2 Europe Intravenous Immunoglobulin (IVIg) Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2017)
6.2.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2017)
6.3 Europe Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Intravenous Immunoglobulin (IVIg) by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
7.1.3 China Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
7.1.4 Japan Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
7.1.5 Korea Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
7.1.6 India Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Application (2013-2018)
8 South America Intravenous Immunoglobulin (IVIg) by Countries, Type, Application and Manufacturers
8.1 South America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Countries
8.1.1 South America Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
8.1.2 South America Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
8.1.3 Brazil Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
8.1.4 Argentina Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
8.1.5 Colombia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
8.2 South America Intravenous Immunoglobulin (IVIg) Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2017)
8.2.2 South America Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2017)
8.3 South America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Type (2013-2018)
8.3.2 South America Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Type (2013-2018)
8.4 South America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Application (2013-2018)
8.4.2 South America Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Intravenous Immunoglobulin (IVIg) by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
9.1.4 UAE Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
9.1.5 Egypt Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
9.1.7 South Africa Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Application (2013-2018)
10 Global Intravenous Immunoglobulin (IVIg) Market Segment by Type
10.1 Global Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type (2013-2018)
10.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2013-2018)
10.2 IVIg Liquid Sales Growth and Price
10.2.1 Global IVIg Liquid Sales Growth (2013-2018)
10.2.2 Global IVIg Liquid Price (2013-2018)
10.3 IVIg Powder Sales Growth and Price
10.3.1 Global IVIg Powder Sales Growth (2013-2018)
10.3.2 Global IVIg Powder Price (2013-2018)
11 Global Intravenous Immunoglobulin (IVIg) Market Segment by Application
11.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2013-2018)
11.2 Immunodeficiency Sales Growth (2013-2018)
11.3 Autoimmune Disease Sales Growth (2013-2018)
11.4 Acute Infection Sales Growth (2013-2018)
12 Intravenous Immunoglobulin (IVIg) Market Forecast (2018-2023)
12.1 Global Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2018-2023)
12.2 Intravenous Immunoglobulin (IVIg) Market Forecast by Regions (2018-2023)
12.2.1 North America Intravenous Immunoglobulin (IVIg) Market Forecast (2018-2023)
12.2.2 Europe Intravenous Immunoglobulin (IVIg) Market Forecast (2018-2023)
12.2.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Forecast (2018-2023)
12.2.4 South America Intravenous Immunoglobulin (IVIg) Market Forecast (2018-2023)
12.2.5 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Forecast (2018-2023)
12.3 Intravenous Immunoglobulin (IVIg) Market Forecast by Type (2018-2023)
12.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2018-2023)
12.3.2 Global Intravenous Immunoglobulin (IVIg) Market Share Forecast by Type (2018-2023)
12.4 Intravenous Immunoglobulin (IVIg) Market Forecast by Application (2018-2023)
12.4.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2018-2023)
12.4.2 Global Intravenous Immunoglobulin (IVIg) Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Intravenous Immunoglobulin (IVIg) Picture
Table Product Specifications of Intravenous Immunoglobulin (IVIg)
Figure Global Intravenous Immunoglobulin (IVIg) CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Intravenous Immunoglobulin (IVIg) CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Intravenous Immunoglobulin (IVIg) by Types in 2017
Figure IVIg Liquid Picture
Table Major Manufacturers of IVIg Liquid
Figure IVIg Powder Picture
Table Major Manufacturers of IVIg Powder
Figure Intravenous Immunoglobulin (IVIg) Sales Market Share by Applications in 2017
Figure Immunodeficiency Picture
Figure Autoimmune Disease Picture
Figure Acute Infection Picture
Figure United States Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure France Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure UK Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure China Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure India Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Table Baxter Headquarter, Established, Main Business and Finance Overview (2017)
Table Baxter Intravenous Immunoglobulin (IVIg) Production Bases, Sales Regions and Major Competitors
Table Baxter Intravenous Immunoglobulin (IVIg) Product
Table Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Baxter Intravenous Immunoglobulin (IVIg) Sales Market Share in 2017
Figure Global Baxter Intravenous Immunoglobulin (IVIg) Revenue Market Share in 2017
Table Grifols Headquarter, Established, Main Business and Finance Overview (2017)
Table Grifols Intravenous Immunoglobulin (IVIg) Production Bases, Sales Regions and Major Competitors
Table Grifols Intravenous Immunoglobulin (IVIg) Product
Table Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Grifols Intravenous Immunoglobulin (IVIg) Sales Market Share in 2017
Figure Global Grifols Intravenous Immunoglobulin (IVIg) Revenue Market Share in 2017
Table CSL Headquarter, Established, Main Business and Finance Overview (2017)
Table CSL Intravenous Immunoglobulin (IVIg) Production Bases, Sales Regions and Major Competitors
Table CSL Intravenous Immunoglobulin (IVIg) Product
Table CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global CSL Intravenous Immunoglobulin (IVIg) Sales Market Share in 2017
Figure Global CSL Intravenous Immunoglobulin (IVIg) Revenue Market Share in 2017
Table Octapharma Headquarter, Established, Main Business and Finance Overview (2017)
Table Octapharma Intravenous Immunoglobulin (IVIg) Production Bases, Sales Regions and Major Competitors
Table Octapharma Intravenous Immunoglobulin (IVIg) Product
Table Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Octapharma Intravenous Immunoglobulin (IVIg) Sales Market Share in 2017
Figure Global Octapharma Intravenous Immunoglobulin (IVIg) Revenue Market Share in 2017
Table Biotest Headquarter, Established, Main Business and Finance Overview (2017)
Table Biotest Intravenous Immunoglobulin (IVIg) Production Bases, Sales Regions and Major Competitors
Table Biotest Intravenous Immunoglobulin (IVIg) Product
Table Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Biotest Intravenous Immunoglobulin (IVIg) Sales Market Share in 2017
Figure Global Biotest Intravenous Immunoglobulin (IVIg) Revenue Market Share in 2017
Table Kedrion Headquarter, Established, Main Business and Finance Overview (2017)
Table Kedrion Intravenous Immunoglobulin (IVIg) Production Bases, Sales Regions and Major Competitors
Table Kedrion Intravenous Immunoglobulin (IVIg) Product

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report